Pangaea Oncology
Pan Oncology is dedicated to advancing cancer research and treatment, with a focus on precision oncology, innovative therapies, and supporting early-career researchers. The company is involved in various initiatives including liquid biopsy congresses, oncology innovation centers, and collaborations with hospitals and research institutes.
Industries
Nr. of Employees
medium (51-250)
Pangaea Oncology
Products
Molecular diagnostics
Offers a range of tests to detect genetic alterations in tumors across all cancer types.
DX platforms Validation
Provides molecular companion diagnostics tests to identify patients likely to benefit from specific treatments.
Pre-clinical services
Combines preclinical cancer research with R&D diagnostics, offering pathology, molecular biology, and various in-vitro and in-vivo techniques.
BIOMARKER DISCOVERY
Focuses on identifying genes involved in cancer to develop novel molecular diagnostic tools and improve patient care.
IN-VITRO TESTING
Offers drug and vaccine effect studies, biomarker discovery, and molecular characterization of cellular models.
MULTIPLEXED PANELS IN OTHER LIQUIDS
Develops multiplex assays for biological fluids other than blood, aiming at diagnostic and predictive value in solid tumors.
Molecular diagnostics
Offers a range of tests to detect genetic alterations in tumors across all cancer types.
DX platforms Validation
Provides molecular companion diagnostics tests to identify patients likely to benefit from specific treatments.
Pre-clinical services
Combines preclinical cancer research with R&D diagnostics, offering pathology, molecular biology, and various in-vitro and in-vivo techniques.
BIOMARKER DISCOVERY
Focuses on identifying genes involved in cancer to develop novel molecular diagnostic tools and improve patient care.
IN-VITRO TESTING
Offers drug and vaccine effect studies, biomarker discovery, and molecular characterization of cellular models.
MULTIPLEXED PANELS IN OTHER LIQUIDS
Develops multiplex assays for biological fluids other than blood, aiming at diagnostic and predictive value in solid tumors.